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INTRODUCTION
Postoperative Urinary Retention (POUR):
What Are The Risk Factors?
Eric H. Tischler BA, Camilo Restrepo MD, Jennipher Oh BA, Mitchell Maltenfort BS, PhD, Javad Parvizi MD, FRCS.
Investigation performed at the Rothman Institute of Orthopaedics at Thomas Jeerson University Hospital, Philadelphia, PA.
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Table 1. Comparison of demographics between cases and matched patients.
BMI=Body mass index; kg= Kilogram; m2= square meter; ASA=American society of anesthesiologists.
 Total hip arthroplasty (THA) is a successful procedure alleviating pain in pa-
tients with debilitating arthritis. Postoperative urinary retention (POUR) is a 
common complication following surgery and is managed with intermittent or 
continued urinary catheterization. POUR has been estimated in retrospective lit-
erature to be on the order of 5% – 70% of surgical cases with early catheter re-
moval or without a catheter. At our institution, and based on a Level 1 study here, 
urinary catheter is not used routinely in patients undergoing THA under regional 
anesthesia. The purpose of this study was to evaluate the incidence of POUR and 
risk factors leading to urinary retention in patients undergoing THA using re-
gional anesthesia who did not receive urinary catheterization.
 A retrospective analysis was conducted to determine specic risk factors for 
POUR following THA. Between June 2010 and June 2012, 422 consecutive THA 
patients were identied, all of whom were operated on by a single surgeon, re-
ceived uniform spinal anesthesia, and did not receive an intraoperative indwell-
ing catheter. POUR was dened as the need for either straight catheterization or 
placement of indwelling catheter following surgical intervention. A multivariate 
logistic regression was used to determine the risk factors that were associated 
with POUR. 
 It has been consistently documented that spinal opiods inuence bladder 
functions and have the potential to cause urinary retention1; hence in our cohort, 
all patients received spinal anesthesia without opiod use. Kuipers et al. deter-
mined that intrathecal administration of opioids (morphine and sufentanil) de-
crease bladder function by causing suppression of detrusor contractility and de-
creased sensation of urge1, 2. 
 Additionally, these same patients did not receive an intraoperative foley 
catheter. Urinary catheters are often placed unnecessarily, and are not always re-
moved promptly when no longer needed. Miller et al. reported no statistical dif-
ference in POUR rates following THA among a cohort of patients that were pro-
spectively randomized to potentially receive an intraoperative foley catheter3.
 A variety of other factors have also been noted to increase the risk of devel-
oping POUR. It was determined that a reported history of BPH and history or uri-
nary complications had signicant impacts on patients developing POUR. These 
risk factors are consistent with other studies. In our study, we noted that patients 
with history of BPH, urinary history, and use of tobacco have increased risk of 
POUR. In an environment where postoperative complications can negatively 
aect hospital and physician reimbursement, we recommend increased surveil-
lance of these patients to appropriately manage expectations and decrease com-
plication rates.
Table 2: Risk Factors Found Signicant for POUR in Multivariate Anaylsis.
Signicance = p-value <0.05
CI=Condence interval;I V= Intaravenous.
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DISCUSSION
 Patients had a signicantly higher incidence of POUR if a history of benign 
prostatic hyperplasia (BPH) (p =0.008), previous urinary complications (p = 
0.0003), and use of tobacco (p = 0.06) was reported. The amount of intravenous 
uid administered to patients during the intraoperative period and bilateral sur-
gery both approached signicance with respective p-values of 0.1. 
TABLES 1 & 2 
Demographics Mean Range
Age (years) 62 24-89
Gender 211 Females
214 Males
BMI (kg/m2) 27.8 16.1- 43.4
(ASA) 2.3 2-3
Risk Factor Odds ratio (95% CI) p-value
Bilateral Procedure 3.10 (0.78-12.33) 0.10
Tobacco Use 2.38 (0.94-6.02) 0.06
Benign Prostate 
Hypertrophy
4.69 (1.48-14.90) 0.008
Urinary Complication 
History
13.78 (3.31-57.52) 0.003
Intraoperative IV Fluid 1.54 (0.91-2.63) 0.10
